Tag: KBIO

Blue Horseshoe Stocks: VXX Options & More

iPath S&P 500 VIX ST Futures ETN (VXX) – Options

We were just mentioning our daily live trader’s chats* in yesterday morning’s report, so we thought we’d give our readers another peek into the activity that goes on in the room. Yesterday around lunchtime, as you can see from the included screenshot below, we were observing the market action caused by the FOMC meeting that was in session at the time.

We noticed new highs in the VXX and signaled our interest in the $19 Calls. We also looked at the SPY, which generally trades inversely to the VXX, and alerted on the $207 Puts; both ideas worked quite well. The VXX $19 Calls ran from .49 to 1.52, a 201% intraday pop. The Spy $207 Puts also offered a nice opportunity as they ran more than 130% from the low 1.30’s to over 3.00.

To follow up with these ideas today, based on premarket activity, we are currently anticipating of a reversal from yesterday’s trends and will thus radar SPY $206-207 Calls, and VXX $20 and 19.50 Puts. However, if the VXX were to break its premarket high of 19.70, it would cause us to flip our targets back to the other side of the fence, so we’ll need to be extremely tuned in once the session gets moving.

*For those that didn’t catch yesterday’s reminder- we welcome any of our readers to get involved with our daily traders chats by sending a Skype contact request to ‘stocksumo’.

Avon Products, Inc. AVP

We’re going to place AVP on watch today as well, due to a number of factors. Setting aside the potentiality of an upcoming buyout of its North American business which has met with some resistance (View Article), AVP is setting itself up one heck of a chart. In today’s premarket trading the stock has breached the resistance line we identify on the following snapshot. There appears to be a good chance to see AVP add to its recent gains which have been fairly steady in recent weeks.

Despite public dissent from one of its large stakeholders, it appears that AVP will still attempt to move forward with their exploration of a proposed buyout (View PR), so it will be very interesting to track this play as that story continues to unfold.

Extended Watchlist:
KBIO, MKAU, HCTI, BCCI, AMBS, ABHI (Bottom-bouncer)

Blue Horseshoe Stocks: Wrapping Up an Awesome Short Week

Magnum Hunter Resources Corp. MHRC

We really couldn’t have laid things out more plainly on Wednesday morning with respect to MHRC. We mentioned that we’d followed the stock all the way from our initial alert on 11/16 from a low of .021 to Tuesday’s high of .074 for a total increase of 252%

We then made it a point to remind our readers that there were still gaps to the upside to fill on the chart, which created the real possibility for further gains. The first gap we identified was from .08-.15 and sure enough, MHRC rose to meet the challenge, nearly filling that gap in its entirety.

The stock began from a morning low of .065 and reached as high as .146, which worked out to an intraday move of 125% and brought our overall observed range (.021-.146) to a mammoth 595%

We still need to keep a close eye on MHRC moving forward. The stock closed with strength at .137 on heavy volume, retaining its momentum-play status.

AgriEuro Corp. EURI

EURI was another momentum mover that up until Wednesday’s report had already shown us a 400% swing to the upside, and it too made a sizable intraday run leading into the holiday break.

The stock traded in a daily range from 1.15 to 1.69 giving traders a shot at modest yet solid intraday profits of 47%

We may look to cut-and-run from this point, as EURI has just been relegated to Caveat Emptor status by OTC Markets.

The Bon-Ton Stores, Inc. BONT

We’ve had success tracking BONT in the past, and this week has been a case of history repeating. We executed a textbook bottom bounce call on BONT, tagging it on Monday before observing a low of 1.25, and both Tuesday and Wednesday’s sessions produced bigtime advances of the chart.

It led to a high of 2.49 Wednesday, (+99%) leaving us just one percent shy of a perfect double-bagger on the week.


Pfizer, Inc. PFE – Options

Despite the recent uproar of excellent calls on various stocks, we didn’t want to break for the holiday without submitting a quick options-trading idea, and the one we identified was PFE Weekly $31-32.50 Calls, based on the premarket activity we were observing Wednesday morning.

Significant intraday spikes occurred in each set of contracts within that range, including a pair of four-baggers!

$31 Calls – Trading Range: 1.13-1.92  – Max Gain: 70%
$31.50 Calls – Trading Range: .62-1.60  – Max Gain: 158%
$32 Calls – Trading Range: .24-1.20 – Max Gain: 400%
$32.50 Calls – Trading Range: .13-.66 – Max Gain: 408%

If the bullish activity continues along a similar trend during today’s short session, we may look for quick-strike opportunities in a higher strike range. We’ll radar the PFE Weekly $32-33.50 Calls, but just remember that trading ceases at 1PM Eastern today, at which time all weekly options will expire! 

Extended Watchlist:
DBMM, FDBL, HPTG, IFCR, LTNC, EFUT, KBIO, AEZS

Blue Horseshoe Stocks: Pharma Watchlist & More

Lexicon Pharmaceuticals, Inc. LXRX

We’re taking notice of LXRX this morning in the wake of a premarket PR that has the stock trending up to its highest levels of the past three months; it contained updates on current projects as well as increased earnings. The addition of an interesting setup on the chart gives us good reason to place LXRX on watch this mid-week.

As you can see on the snapshot below, the stock gapped down significantly at the end of November. In premarket activity today we’re seeing a partial fill taking place. We’re going to be watching for LXRX to fill the remainder of the gap into the mid 1.20’s where its next area of resistance will come in at the 200DMA of 1.28.

THE WOODLANDS, Texas, March 4, 2015 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.>> VIEW PR

Pharmaceutical Watchlist

There are a number of other pharma and biopharma stocks gapping up in the premarket this morning, some of which have appeared in our reports in the past. We’ve listed them below along with links to today’s news, where applicable:

Keryx Biopharmaceuticals, Inc. KERX


Atossa Genetics, Inc. ATOS


Coronado Biosciences, Inc. CNDO

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies (Wed 8:30AM EST)

PhotoMedex, Inc. PHMD

Orexigen Therapeutics, Inc. OREX

KaloBios Pharmaceuticals, Inc. KBIO

Earnings-Related Options Ideas

American Eagle Outfitters, Inc. AEO beat expected Q4 profits and revenues, and is gapping up as a result. To take advantage of the trend, we are monitoring options trading possibilities in the AEO Weekly $15-16 Calls

Abercrombie & Fitch ANF fell short of expectations with regard to sales, which is fueling a downtrend here in the premarket, so we’ll take the opposite approach here, and keep an eye on ANF Weekly $23-24 Puts.

Extended Watchlist:
IFON, PLUG, NPTN, WLT, LEI